logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Thibault De La Motte Rouge

eugène marquis comprehensive cancer center

31H-index
239Paper Count
5.8KCitation Count
Published Papers 80
Publication Date
logo
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
errAnnals of Oncology
IF65.4
err2025-11-17
err0
PREAI
errL. Cabel; F. Berger; T. Bachelot; B. Pistilli; F. Dalenc; T.de la Motte Rouge; R. Sabatier; A. Lortholary; S. Marques; J. Vibert; S. Renault; A.C. Hardy-Bessard; S. Delaloge; A. Pradines; C. Callens; F.C. Bidard
errShare
errSave
Surgical Approach and Maintenance Therapy in Advanced Low-Grade Serous Ovarian Cancer: Insights from the French ESME Database
errInternational Journal of Gynecological Cancer
IF4.7
err2025-11-14
err0
PREAI
errT. Papazyan; E. Martin; P. Pautier; C. Guerin-Charbonnel; E. Rowinski; F. Lecuru; F.Joly Lobbedez; T. De La Motte Rouge; C. Guillemet; H. Costaz; R. Sabatier; E. Barranger; P.E. Colombo; F. Marchal; C. Pomel; A.M. Savoye; L. Bosquet; I. Ray-Coquard; L. Gladieff; C. Loaec
errShare
errSave
Comparative performance of a targeted next-generation sequencing assay against multiplexed digital PCR assays in detecting ERBB2, ESR1, and PIK3CA mutations in plasma circulating cell-free DNA from liquid biopsies
errThe Journal of Molecular Diagnostics
IF0
err2025-10-08
err0
PREAI
errJulien Corné; Florence Godey; Angelina Legros; Laurent Castéra; Sophie Krieger; Mathilde Cherel; Agathe Cochet; Fanny Le Du; Héloïse Bourien; Antoine Deleuze; Laurence Crouzet; Christophe Perrin; Claudia Lefeuvre-Plesse; Véronique Diéras; Thibault De la Motte Rouge
errShare
errSave
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database
errgynecologic oncology
IF4.1
err2025-08-07
err0
PREAI
errClaire Chator; Marion Chevrier; Jean-Sébastien Frenel; Frédéric Guyon; Renaud Sabatier; Christophe Pomel; Thibault de la motte Rouge; Patricia Pautier; Laurence Gladieff; Philippe Follana; Pierre-Emmanuel Colombo; Thierry Petit; Cécile Guillemet; Frederic Marchal; Fabrice Narducci; Jean-David Fumet; Manuel Rodrigues; Lise Bosquet; Roman Rouzier; Isabelle Ray-Coquard
errShare
errSave
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer
errAnnals of Oncology
IF65.4
err2025-07-05
err0
PREAI
errA. Mamann; Y. Pradat; F.C. Bidard; S. Delaloge; L. Cabel; I. Faull; S. Marques; T. Bachelot; F. Dalenc; T. de la Motte Rouge; B. Pistilli; J. Samaniego; J.S. Frenel; C. Levy; J.M. Ferrero; R. Sabatier; S. Ladoire; C. Chakiba; A.C. Hardy; J. Lemonnier; Y. Mahi; F. Andre; P.H. Cournede; S. Michiels; E. Bernard
errShare
errSave
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network
errONCOLOGIST
IF4.2
err2025-05-11
err0
errOAAI
errRippstein, Nicolas; Zemmour, Christophe; Rodrigues, Manuel; Ray-Coquard, Isabelle; Gladieff, Laurence; Pautier, Patricia; Frenel, Jean-Sebastien; Costaz, Helene; Lebreton, Coriolan; Pomel, Christophe; Colombo, Pierre-Emmanuel; Marchal, Frederic; Guillemet, Cecile; Rouge, Thibault de la Motte; Eberst, Lauriane; Bosquet, Lise; Deluche, Elise; Sabatier, Renaud
errShare
errSave
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer
errInternational Journal of Gynecological Cancer
IF4.7
err2025-04-19
err0
errOAAI
errAlejandro Perez-Fidalgo; Barbara Schmalfeldt; Angela George; Charlie Gourley; Sandro Pignata; Domenica Lorusso; Maria Pilar Barretina-Ginesta; Ignacio Romero; Christoph Grimm; Toon Van Gorp; Maria Rossing; Dearbhaile C. Collins; Josefin Fernebro; Line Bjørge; Alexandra Leary; Thibault de la Motte Rouge; Philipp Harter; Christian Kurzeder; Joana Savva-Bordalo; Benoit You
errShare
errSave
Advanced High-Grade Serous Ovarian Cancer Treated With Intensive Cytoreductive Surgery And Chemotherapy: Prognostic Impact Of Lymph Node Involvement: Analysis Of The French National ESME-Unicancer Database
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-02-01
err0
PREAI
errLoaec, Cecile; Le Bars, Sophie; Guerin-Charbonneli, Catherine; Martin, Elodie; Thomas, Quentin Dominique; Costaz, Helene; Pomel, Christophe; Marchal, Frederic; Narducci, Fabrice; Gouy, Sebastien; Laas, Enora; Rossi, Lea; Lambaudie, Eric; Rouzier, Roman; Petit, Thierry; Gladieff, Laurence; Rouge, Thibault De La Motte; Bosquet, Lise; Colombo, Pierre-Emmanuel; Classe, Jean-Marc; Bouvarel, Barnabe
errShare
errSave
A Retrospective Multicentre Study To Evaluate The Impact Of Platinum-Free Interval On Progression-Free And Overall Survival In Patients With Recurrent Epithelial Ovarian Cancer, Using Real-World Data From The ESME Database
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-02-01
err0
PREAI
errChator, Claire; Chevrier, Marion; Frenel, Jean-Sebastien; Guyon, Frederic; Sabatier, Renaud; Pomel, Christophe; Rouge, Thibault De La Motte; Gladieff, Laurence; Follana, Philippe; Colombo, Pierre-Emmanuel; Petit, Thierry; Guillemet, Cecile; Marchal, Frederic; Narducci, Fabrice; Fumet, Jean-David; Rodrigues, Manuel; Bosquet, Lise; Rouzier, Roman; Coquard, Isabelle Ray
errShare
errSave
Surgical Outcomes In Low-Grade Serous Ovarian Cancer: Comparing Primary Debulking Surgery With Neoadjuvant Chemotherapy
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-02-01
err0
PREAI
errMadar, Alexandra; Hotton, Judicael; Bats, Anne-Sophie; Gauroy, Elodie; Laas, Enora; Marchal, Frederic; Loaec, Cecile; Colombo, Pierre-Emmanuel; Belda, Marie-Aude; Gouy, Sebastien; Bonneau, Claire; Guyon, Frederic; Pomel, Christophe; Lortholary, Alain; Berton-Rigaud, Dominique; Lambaudie, Eric; Rouge, Thibault De La Motte; Ray-Coquard, Isabelle; Gaillard, Thomas; Lecuru, Fabrice
errShare
errSave
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2025-01-07
err1
errOAAI
errFrenel, Jean-Sebastien; Mathiot, Laurent; Cropet, Claire; Borcoman, Edith; Hervieu, Alice; Coquan, Elodie; de la Motte Rouge, Thibault; Saada-Bouzid, Esma; Sabatier, Renaud; Lavaud, Pernelle; Jimenez, Marta; Legrand, Francois; Le Saux, Olivia; Charafe, Emmanuelle; Goncalves, Anthony
errShare
errSave
Phase 1 expansion results of IDE397, a first-in-class, oral, MAT2A inhibitor (MAT2Ai) in MTAP deleted(del) non-small cell lung cancer (NSCLC) and urothelial cancer (UC)
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-10-01
err0
PREAI
errHerzberg, B.; Johnson, M.; Kim, C. G.; Tolcher, A.; Rodon, J.; Mantia, C.; Liu, J.; Tripathi, A.; Rodriguez, L. Paz-Ares; Rouge, T. De la Motte; Choi, C. M.; Han, J. Y.; Kwei, L.; Liu, E.; Sachdev, J.; O'Quigley, M.; White, M.; Beaupre, D.; Kim, H. R.
errShare
errSave
Tolerability of the niraparib individualized starting dose in the PRIMA/ ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err1
PREAI
errVulsteke, Christof; Chambers, Setsuko K.; Perez, Maria Jesus Rubio; Chan, John K.; Raaschou-Jensen, Nicoline; Zhuo, Ying; Lorusso, Domenica; Herzog, Thomas J.; Rouge, Thibault de la Motte; Pepin, Jessica A. Thomes; Braicu, Elena Ioana; Chen, Lee-may; Levy, Tally; Barter, James F.; Barretina-Ginesta, M. Pilar; Joosens, Eric; York, Whitney; Malinowska, Izabela A.; Gonzalez-Martin, Antonio; Monk, Bradley J.
errShare
errSave
TEDOVA: vaccine OSE2101+/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer
errFUTURE ONCOLOGY
IF2.6
err2024-08-19
err0
PREAI
errKabirian, Rayan; Tredan, Olivier; Marme, Frederik; Paoletti, Xavier; Eberst, Lauriane; Lebreton, Coriolan; Rouge, Thibault De La Motte; Sabatier, Renaud; Angelergues, Antoine; Fabbro, Michel; Van Gorp, Toon; Mansi, Laura; Gladieff, Laurence; Kaczmarek, Emilie; Alexandre, Jerome; Grellety, Thomas; Favier, Laure; Welz, Julia; Frenel, Jean-Sebastien; Leary, Alexandra
errShare
errSave
Impact of hormone receptor expression level in HR+/HER2-metastatic breast cancer in the large French ESME cohort
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errAlexandre, Marie; Castan, Florence; Rouge, Thibault De La Motte; Mailliez, Audrey; Brain, Etienne; Bachelot, Thomas; Arnedos, Monica; Dalenc, Florence; Ferrero, Jean-Marc; Massard, Vincent; Desmoulins, Isabelle; Mouret-Reynier, Marie-Ange; Levy, Christelle; Goncalves, Anthony; Berghian, Anca; Savoye, Aude-Marie; Frenel, Jean-Sebastien; Bosquet, Lise; Delaloge, Suzette; Jacot, William
errShare
errSave
A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errRosenberg, Jonathan; Sabatier, Renaud; Viceneux, Armelle; Rouge, Thibault De la Motte; Champiat, Stephane; Lebellec, Loic; Barthelemy, Philippe; Sonpavde, Guru; Gao, Xin; Niglio, Scot; Zhang, Tian; Gedye, Craig; Galsky, Matthew; Milowsky, Matthew; Reimers, Melissa; Weickhardt, Andrew; Grande, Enrique; Castellano, Daniel E.; Bilen, Mehmet; Patnaik, Amita; Zerbib, Robert; Balbas, Minna; Xu, Xiaojian; Aptaker, Kaitlyn; Balar, Arjun V.; Awada, Ahmad H.
errShare
errSave
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2+BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-03-07
err0
errOAAI
errGinzac, Angeline; Molnar, Ioana; Durando, Xavier; De La Motte Rouge, Thibault; Petit, Thierry; D'hondt, Veronique; Campone, Mario; Bonichon-Lamichhane, Nathalie; Venat Bouvet, Laurence; Levy, Christelle; Augereau, Paule; Pistilli, Barbara; Arsene, Olivier; Nguyen, Suzanne; Jouannaud, Christelle; Cayre, Anne; Tixier, Lucie; Mahier Ait Oukhatar, Celine; Nabholtz, Jean-Marc; Penault-Llorca, Frederique; Mouret-Reynier, Marie-Ange
errShare
errSave
Plasma-based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer
errMOLECULAR ONCOLOGY
IF4.5
err2024-01-29
err4
errOAAI
errCorne, Julien; Quillien, Veronique; Godey, Florence; Cherel, Mathilde; Cochet, Agathe; Le Du, Fanny; Robert, Lucie; Bourien, Heloise; Brunot, Angelique; Crouzet, Laurence; Perrin, Christophe; Lefeuvre-Plesse, Claudia; Dieras, Veronique; de la Motte Rouge, Thibault
errShare
errSave
Impact of consolidation cycles in predicting recurrence in patients treated with EMA-CO for high-risk gestational trophoblastic neoplasia
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errDeleuze, A.; Hajri, T.; Bolze, P. A.; Rouge, T. De La Motte
errShare
errSave
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2023-08-01
err8
PREAI
errGrinda, Thomas; Antoine, Alison; Jacot, William; Cottu, Paul-Henri; Rouge, Thibault de la Motte; Frenel, Jean-Sebastien; Mailliez, Audrey; Dalenc, Florence; Goncalves, Anthony; Clatot, Florian; Reynier, Marie-Ange Mouret; Levy, Christelle; Ferrero, Jean-Marc; Desmoulins, Isabelle; Uwer, Lionel; Petit, Thierry; Jouannaud, Christelle; Arnedos, Monica; Chevrot, Michael; Courtinard, Coralie; Tredan, Olivier; Brain, Etienne; Perol, David; Pistilli, Barbara; Delaloge, Suzette
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Guido Kroemer
H-index: 283 · Papers: 2.3K
L
Laurence Zitvogel
H-index: 165 · Papers: 1.2K
J
Jean‐Yves Blay
H-index: 158 · Papers: 2.4K
I
Ignacio I. Wistuba
H-index: 153 · Papers: 2.8K
L
Lorenzo Galluzzi
H-index: 153 · Papers: 988
View more